Omega Pharma is a Belgian

Belgium

Belgium , officially the Kingdom of Belgium, is a federal state in Western Europe. It is a founding member of the European Union and hosts the EU's headquarters, and those of several other major international organisations such as NATO.Belgium is also a member of, or affiliated to, many...

 Pharmaceutical company, founded in 1987 by Marc Coucke

Marc Coucke

Marc Coucke is a Belgian businessman. He studied pharmacology at the University of Ghent and obtained a Master in General Management from the Vlerick Leuven Gent Management School....

 (born 1965) and Yvan Vindevogel, both former Pharmacy students at the Ghent University

Ghent University

Ghent University is a Dutch-speaking public university located in Ghent, Belgium. It is one of the larger Flemish universities, consisting of 32,000 students and 7,100 staff members. The current rector is Paul Van Cauwenberge.It was established in 1817 by King William I of the Netherlands...

.

The company is quoted at Euronext

Euronext

Euronext N.V. is a pan-European stock exchange based in Amsterdam and with subsidiaries in Belgium, France, Netherlands, Portugal and the United Kingdom. In addition to equities and derivatives markets, the Euronext group provides clearing and information services...

 Brussels and makes part of the BEL20

BEL20

The BEL20 is the benchmark stock market index of Euronext Brussels. In general, the index consists of a minimum of 10 and a maximum of 20 companies traded at the Brussels Stock Exchange. Since 20 June 2011, the BEL20 has contained 20 listings.-Rules:...

index.

Arseus

At the occasion of the annual shareholders meeting of June 6th 2006; Omega Pharma announced the name under which its Professional Health division will henceforward operate: Arseus. Simultaneously, the management team of Arseus was presented. The legal structure of the entities in this division has been largely prepared in the mean time, so that the project to make Arseus an autonomous company is on schedule. In the framework of this project, it is expected that Arseus, as an autonomous company, will become stock-listed by 2008.